{
    "info": {
        "nct_id": "NCT06411691",
        "official_title": "Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Adenocarcinoma",
        "inclusion_criteria": "* Age â‰¥18 years.\n* Have histologically or cytologically - proven cancer of the pancreas or colon.\n* Have tumor lesions amenable to repeated biopsy, and patient's acceptance to have a tumor biopsy of an accessible lesion at baseline and on treatment if the lesion can be biopsied with acceptable clinical risk (as judged by the investigator).\n* Measurable disease as per RECIST 1.1.\n* Have sufficient and accessible tissue for next generation sequencing (NGS) and immune-phenotyping.\n* Have one of the KRAS mutations included in the vaccine at the time of vaccination expressed in tumor.\n* Cohort A: Have received 4-6 months of FOLFIRINOX or gemcitabine+nab-paclitaxel for the 1st line treatment of metastatic unresectable PDAC.\n* Cohort B: Have received 4-6 months of 1st line SOC chemotherapy per NCCN guidelines (FOLFIRINOX, FOLFOX, FOLFIRI +/- targeted therapy with VEGFi or EGFRi) of metastatic CRC.\n* Cohort C: Have received no more than 3 lines of systemic chemotherapy, including prior KRAS inhibitor.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0.\n* Life expectancy of greater than 3 months.\n* Patients must have adequate organ and marrow function defined by study-specified laboratory tests prior to initial study drug.\n* Woman of childbearing potential must have a negative pregnancy test and follow contraceptive guidelines as defined per protocol.\n* Men must use acceptable form of birth control while on study.\n* Ability to understand and willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Is a candidate for definitive surgical resection.\n* Known history or evidence of brain metastases and/or leptomeningeal spread.\n* Prior treatment with immunotherapy agents (including, anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4, etc.).\n* Receiving active immunosuppressive agents or chronic use of systemic corticosteroids within 14 days of vaccine treatment.\n* Has active autoimmune disease that has required systemic treatment in the past 5 years, or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents.\n* Known history or concurrent interstitial lung disease.\n* Has a pulse oximetry < 95% on room air.\n* Requires the use of home oxygen.\n* Infection with HIV or hepatitis B or C.\n* Uncontrolled intercurrent illness including, but not limited to, uncontrolled infection, symptomatic congestive heart failure, unstable angina, cardiac arrhythmia, metastatic cancer, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Has been diagnosed with another cancer or myeloproliferative disorder in the past 5 years except for superficial bladder cancer, non-melanoma skin cancers, DCIS, a low-grade prostate cancer, or a cancer not expected to impact life expectancy and not requiring therapy.\n* Has had surgery within 28 days of dosing of investigational agent, excluding minor procedures (dental work, skin biopsy, etc.), celiac plexus block, and biliary stent placement.\n* Has received any non-oncology live vaccine therapy used for prevention of infectious diseases within 28 days of study treatment.\n* If at the time of signing informed consent, a regular user (including \"recreational use\") of any illicit drugs or other substance abuse (including alcohol) that could potentially interfere with adherence to study procedures or requirements.\n* Any other sound medical, psychiatric, and/or social reason as determined by the Investigator.\n* Unwilling or unable to follow the study schedule for any reason.\n* Are pregnant or breastfeeding.\n* Any radiological or clinical pleural effusions or ascites.\n* History of malignant small bowel obstruction.\n* On parenteral nutrition.\n* Known or suspected hypersensitivity to Hiltonol.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Life expectancy of greater than 3 months.",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy of greater than 3 months",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have adequate organ and marrow function defined by study-specified laboratory tests prior to initial study drug.",
            "criterions": [
                {
                    "exact_snippets": "adequate organ and marrow function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate organ and marrow function",
                    "criterion": "marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Men must use acceptable form of birth control while on study.",
            "criterions": [
                {
                    "exact_snippets": "Men must use acceptable form of birth control while on study.",
                    "criterion": "male participants",
                    "requirements": [
                        {
                            "requirement_type": "use of acceptable birth control",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time period",
                            "expected_value": "while on study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status 0.",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "=",
                                "value": 0,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have one of the KRAS mutations included in the vaccine at the time of vaccination expressed in tumor.",
            "criterions": [
                {
                    "exact_snippets": "Have one of the KRAS mutations included in the vaccine at the time of vaccination expressed in tumor",
                    "criterion": "KRAS mutation in tumor",
                    "requirements": [
                        {
                            "requirement_type": "mutation type",
                            "expected_value": "one of the KRAS mutations included in the vaccine at the time of vaccination"
                        },
                        {
                            "requirement_type": "expression",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to understand and willingness to sign a written informed consent document.",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand",
                    "criterion": "cognitive ability to understand informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have sufficient and accessible tissue for next generation sequencing (NGS) and immune-phenotyping.",
            "criterions": [
                {
                    "exact_snippets": "sufficient and accessible tissue for next generation sequencing (NGS) and immune-phenotyping",
                    "criterion": "tissue",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": "sufficient"
                        },
                        {
                            "requirement_type": "accessibility",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "intended_use",
                            "expected_value": [
                                "next generation sequencing (NGS)",
                                "immune-phenotyping"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Measurable disease as per RECIST 1.1.",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease as per RECIST 1.1.",
                    "criterion": "disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_criteria",
                            "expected_value": "RECIST 1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cohort C: Have received no more than 3 lines of systemic chemotherapy, including prior KRAS inhibitor.",
            "criterions": [
                {
                    "exact_snippets": "Have received no more than 3 lines of systemic chemotherapy",
                    "criterion": "lines of systemic chemotherapy received",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "lines"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "including prior KRAS inhibitor",
                    "criterion": "prior KRAS inhibitor therapy",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age â‰¥18 years.",
            "criterions": [
                {
                    "exact_snippets": "Age â‰¥18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Woman of childbearing potential must have a negative pregnancy test and follow contraceptive guidelines as defined per protocol.",
            "criterions": [
                {
                    "exact_snippets": "Woman of childbearing potential",
                    "criterion": "sex and reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must have a negative pregnancy test",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy test result",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "follow contraceptive guidelines as defined per protocol",
                    "criterion": "contraceptive use",
                    "requirements": [
                        {
                            "requirement_type": "adherence to contraceptive guidelines",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have tumor lesions amenable to repeated biopsy, and patient's acceptance to have a tumor biopsy of an accessible lesion at baseline and on treatment if the lesion can be biopsied with acceptable clinical risk (as judged by the investigator).",
            "criterions": [
                {
                    "exact_snippets": "tumor lesions amenable to repeated biopsy",
                    "criterion": "tumor lesions",
                    "requirements": [
                        {
                            "requirement_type": "amenability to repeated biopsy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "patient's acceptance to have a tumor biopsy",
                    "criterion": "patient's acceptance to tumor biopsy",
                    "requirements": [
                        {
                            "requirement_type": "acceptance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "accessible lesion at baseline and on treatment if the lesion can be biopsied with acceptable clinical risk (as judged by the investigator)",
                    "criterion": "lesion accessibility and biopsy risk",
                    "requirements": [
                        {
                            "requirement_type": "accessibility for biopsy at baseline",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "accessibility for biopsy on treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "acceptable clinical risk for biopsy (as judged by the investigator)",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cohort B: Have received 4-6 months of 1st line SOC chemotherapy per NCCN guidelines (FOLFIRINOX, FOLFOX, FOLFIRI +/- targeted therapy with VEGFi or EGFRi) of metastatic CRC.",
            "criterions": [
                {
                    "exact_snippets": "Have received 4-6 months of 1st line SOC chemotherapy",
                    "criterion": "1st line standard of care (SOC) chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": "months"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "per NCCN guidelines (FOLFIRINOX, FOLFOX, FOLFIRI +/- targeted therapy with VEGFi or EGFRi)",
                    "criterion": "chemotherapy regimen",
                    "requirements": [
                        {
                            "requirement_type": "regimen",
                            "expected_value": [
                                "FOLFIRINOX",
                                "FOLFOX",
                                "FOLFIRI"
                            ]
                        },
                        {
                            "requirement_type": "targeted therapy",
                            "expected_value": [
                                "VEGFi",
                                "EGFRi",
                                "none"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "metastatic CRC",
                    "criterion": "colorectal cancer (CRC)",
                    "requirements": [
                        {
                            "requirement_type": "disease stage",
                            "expected_value": "metastatic"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cohort A: Have received 4-6 months of FOLFIRINOX or gemcitabine+nab-paclitaxel for the 1st line treatment of metastatic unresectable PDAC.",
            "criterions": [
                {
                    "exact_snippets": "Have received 4-6 months of FOLFIRINOX or gemcitabine+nab-paclitaxel",
                    "criterion": "prior chemotherapy regimen",
                    "requirements": [
                        {
                            "requirement_type": "regimen type",
                            "expected_value": [
                                "FOLFIRINOX",
                                "gemcitabine+nab-paclitaxel"
                            ]
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": "months"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "for the 1st line treatment of metastatic unresectable PDAC",
                    "criterion": "line of therapy",
                    "requirements": [
                        {
                            "requirement_type": "line",
                            "expected_value": "1st"
                        }
                    ]
                },
                {
                    "exact_snippets": "for the 1st line treatment of metastatic unresectable PDAC",
                    "criterion": "disease type",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "metastatic unresectable PDAC"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have histologically or cytologically - proven cancer of the pancreas or colon.",
            "criterions": [
                {
                    "exact_snippets": "histologically or cytologically - proven cancer of the pancreas",
                    "criterion": "pancreatic cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": [
                                "histologically proven",
                                "cytologically proven"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "histologically or cytologically - proven cancer of the ... colon",
                    "criterion": "colon cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": [
                                "histologically proven",
                                "cytologically proven"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Unwilling or unable to follow the study schedule for any reason.",
            "criterions": [
                {
                    "exact_snippets": "Unwilling or unable to follow the study schedule for any reason.",
                    "criterion": "ability and willingness to follow study schedule",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any radiological or clinical pleural effusions or ascites.",
            "criterions": [
                {
                    "exact_snippets": "Any radiological or clinical pleural effusions",
                    "criterion": "pleural effusion",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Any radiological or clinical ... ascites",
                    "criterion": "ascites",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Requires the use of home oxygen.",
            "criterions": [
                {
                    "exact_snippets": "Requires the use of home oxygen",
                    "criterion": "home oxygen use",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has a pulse oximetry < 95% on room air.",
            "criterions": [
                {
                    "exact_snippets": "pulse oximetry < 95% on room air",
                    "criterion": "pulse oximetry",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 95,
                                "unit": "%"
                            }
                        },
                        {
                            "requirement_type": "measurement_condition",
                            "expected_value": "on room air"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receiving active immunosuppressive agents or chronic use of systemic corticosteroids within 14 days of vaccine treatment.",
            "criterions": [
                {
                    "exact_snippets": "Receiving active immunosuppressive agents",
                    "criterion": "immunosuppressive agent use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic use of systemic corticosteroids within 14 days of vaccine treatment",
                    "criterion": "systemic corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "chronic use within 14 days of vaccine treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has been diagnosed with another cancer or myeloproliferative disorder in the past 5 years except for superficial bladder cancer, non-melanoma skin cancers, DCIS, a low-grade prostate cancer, or a cancer not expected to impact life expectancy and not requiring therapy.",
            "criterions": [
                {
                    "exact_snippets": "Has been diagnosed with another cancer or myeloproliferative disorder in the past 5 years",
                    "criterion": "diagnosis of another cancer or myeloproliferative disorder",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "except for superficial bladder cancer, non-melanoma skin cancers, DCIS, a low-grade prostate cancer, or a cancer not expected to impact life expectancy and not requiring therapy",
                    "criterion": "type of prior cancer diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "superficial bladder cancer",
                                "non-melanoma skin cancers",
                                "DCIS",
                                "low-grade prostate cancer",
                                "cancer not expected to impact life expectancy and not requiring therapy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known history or concurrent interstitial lung disease.",
            "criterions": [
                {
                    "exact_snippets": "Known history ... interstitial lung disease",
                    "criterion": "interstitial lung disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "concurrent interstitial lung disease",
                    "criterion": "interstitial lung disease",
                    "requirements": [
                        {
                            "requirement_type": "concurrent presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known history or evidence of brain metastases and/or leptomeningeal spread.",
            "criterions": [
                {
                    "exact_snippets": "Known history ... brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "evidence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known history ... leptomeningeal spread",
                    "criterion": "leptomeningeal spread",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of ... leptomeningeal spread",
                    "criterion": "leptomeningeal spread",
                    "requirements": [
                        {
                            "requirement_type": "evidence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has had surgery within 28 days of dosing of investigational agent, excluding minor procedures (dental work, skin biopsy, etc.), celiac plexus block, and biliary stent placement.",
            "criterions": [
                {
                    "exact_snippets": "Has had surgery within 28 days of dosing of investigational agent, excluding minor procedures (dental work, skin biopsy, etc.), celiac plexus block, and biliary stent placement.",
                    "criterion": "surgery",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": "major (excluding minor procedures, celiac plexus block, and biliary stent placement)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known or suspected hypersensitivity to Hiltonol.",
            "criterions": [
                {
                    "exact_snippets": "Known or suspected hypersensitivity to Hiltonol.",
                    "criterion": "hypersensitivity to Hiltonol",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* On parenteral nutrition.",
            "criterions": [
                {
                    "exact_snippets": "On parenteral nutrition.",
                    "criterion": "parenteral nutrition",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has active autoimmune disease that has required systemic treatment in the past 5 years, or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents.",
            "criterions": [
                {
                    "exact_snippets": "Has active autoimmune disease that has required systemic treatment in the past 5 years",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "systemic treatment requirement (past 5 years)",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "documented history of clinically severe autoimmune disease",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "history of clinically severe disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "syndrome that requires systemic steroids or immunosuppressive agents",
                    "criterion": "syndrome requiring immunosuppression",
                    "requirements": [
                        {
                            "requirement_type": "systemic steroids or immunosuppressive agent requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any other sound medical, psychiatric, and/or social reason as determined by the Investigator.",
            "criterions": [
                {
                    "exact_snippets": "Any other sound medical, psychiatric, and/or social reason as determined by the Investigator.",
                    "criterion": "medical, psychiatric, or social reason (as determined by Investigator)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has received any non-oncology live vaccine therapy used for prevention of infectious diseases within 28 days of study treatment.",
            "criterions": [
                {
                    "exact_snippets": "Has received any non-oncology live vaccine therapy used for prevention of infectious diseases within 28 days of study treatment.",
                    "criterion": "receipt of non-oncology live vaccine therapy",
                    "requirements": [
                        {
                            "requirement_type": "time since receipt",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Is a candidate for definitive surgical resection.",
            "criterions": [
                {
                    "exact_snippets": "Is a candidate for definitive surgical resection.",
                    "criterion": "candidate for definitive surgical resection",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Are pregnant or breastfeeding.",
            "criterions": [
                {
                    "exact_snippets": "Are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment with immunotherapy agents (including, anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4, etc.).",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with immunotherapy agents (including, anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4, etc.)",
                    "criterion": "prior treatment with immunotherapy agents",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled intercurrent illness including, but not limited to, uncontrolled infection, symptomatic congestive heart failure, unstable angina, cardiac arrhythmia, metastatic cancer, or psychiatric illness/social situations that would limit compliance with study requirements.",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled intercurrent illness",
                    "criterion": "intercurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina",
                    "criterion": "angina",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": "unstable"
                        }
                    ]
                },
                {
                    "exact_snippets": "cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "metastatic cancer",
                    "criterion": "metastatic cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness or social situations limiting compliance",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": "limits compliance with study requirements"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of malignant small bowel obstruction.",
            "criterions": [
                {
                    "exact_snippets": "History of malignant small bowel obstruction.",
                    "criterion": "malignant small bowel obstruction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* If at the time of signing informed consent, a regular user (including \"recreational use\") of any illicit drugs or other substance abuse (including alcohol) that could potentially interfere with adherence to study procedures or requirements.",
            "criterions": [
                {
                    "exact_snippets": "a regular user (including \"recreational use\") of any illicit drugs",
                    "criterion": "illicit drug use",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": "regular use (including recreational use)"
                        }
                    ]
                },
                {
                    "exact_snippets": "other substance abuse (including alcohol) that could potentially interfere with adherence to study procedures or requirements",
                    "criterion": "substance abuse (including alcohol)",
                    "requirements": [
                        {
                            "requirement_type": "potential to interfere with adherence to study procedures or requirements",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Infection with HIV or hepatitis B or C.",
            "criterions": [
                {
                    "exact_snippets": "Infection with HIV",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis B",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis C",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}